nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP1A2—Imiquimod—skin cancer	0.176	0.224	CbGbCtD
Cinacalcet—CYP1A2—Vemurafenib—skin cancer	0.0965	0.123	CbGbCtD
Cinacalcet—CYP3A4—Temozolomide—skin cancer	0.0922	0.117	CbGbCtD
Cinacalcet—CYP3A4—Imiquimod—skin cancer	0.0922	0.117	CbGbCtD
Cinacalcet—CYP2D6—Vemurafenib—skin cancer	0.0795	0.101	CbGbCtD
Cinacalcet—CYP1A2—Dacarbazine—skin cancer	0.0739	0.0941	CbGbCtD
Cinacalcet—CYP3A4—Vismodegib—skin cancer	0.0639	0.0814	CbGbCtD
Cinacalcet—CYP3A4—Vemurafenib—skin cancer	0.0505	0.0643	CbGbCtD
Cinacalcet—CYP1A2—Fluorouracil—skin cancer	0.0433	0.0552	CbGbCtD
Cinacalcet—CYP3A4—Docetaxel—skin cancer	0.0173	0.0221	CbGbCtD
Cinacalcet—Metastatic neoplasm—Temozolomide—skin cancer	0.00782	0.0388	CcSEcCtD
Cinacalcet—Neoplasm malignant—Vismodegib—skin cancer	0.00556	0.0276	CcSEcCtD
Cinacalcet—Metastatic neoplasm—Docetaxel—skin cancer	0.0052	0.0258	CcSEcCtD
Cinacalcet—Multi-organ failure—Dactinomycin—skin cancer	0.00509	0.0252	CcSEcCtD
Cinacalcet—CASR—neck—skin cancer	0.00493	0.418	CbGeAlD
Cinacalcet—CASR—connective tissue—skin cancer	0.00353	0.3	CbGeAlD
Cinacalcet—Pain in extremity—Vismodegib—skin cancer	0.00345	0.0171	CcSEcCtD
Cinacalcet—Neoplasm malignant—Vemurafenib—skin cancer	0.00344	0.017	CcSEcCtD
Cinacalcet—Dehydration—Vismodegib—skin cancer	0.00321	0.0159	CcSEcCtD
Cinacalcet—Multi-organ failure—Docetaxel—skin cancer	0.00306	0.0152	CcSEcCtD
Cinacalcet—Pain in extremity—Vemurafenib—skin cancer	0.00213	0.0106	CcSEcCtD
Cinacalcet—CASR—head—skin cancer	0.00208	0.177	CbGeAlD
Cinacalcet—Malnutrition—Vismodegib—skin cancer	0.00208	0.0103	CcSEcCtD
Cinacalcet—Muscle spasms—Vismodegib—skin cancer	0.002	0.0099	CcSEcCtD
Cinacalcet—Cardiac failure—Imiquimod—skin cancer	0.00186	0.00923	CcSEcCtD
Cinacalcet—Pain in extremity—Imiquimod—skin cancer	0.00182	0.00901	CcSEcCtD
Cinacalcet—Hypocalcaemia—Dactinomycin—skin cancer	0.00181	0.00898	CcSEcCtD
Cinacalcet—Arthralgia—Vismodegib—skin cancer	0.00177	0.00877	CcSEcCtD
Cinacalcet—Myalgia—Vismodegib—skin cancer	0.00177	0.00877	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00176	0.00871	CcSEcCtD
Cinacalcet—Nervous system disorder—Vismodegib—skin cancer	0.00166	0.00824	CcSEcCtD
Cinacalcet—Skin disorder—Vismodegib—skin cancer	0.00165	0.00816	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00154	0.00766	CcSEcCtD
Cinacalcet—Dyspepsia—Vismodegib—skin cancer	0.00149	0.0074	CcSEcCtD
Cinacalcet—Decreased appetite—Vismodegib—skin cancer	0.00147	0.00731	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Vismodegib—skin cancer	0.00146	0.00726	CcSEcCtD
Cinacalcet—Fatigue—Vismodegib—skin cancer	0.00146	0.00725	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Imiquimod—skin cancer	0.00146	0.00724	CcSEcCtD
Cinacalcet—Oedema peripheral—Vemurafenib—skin cancer	0.00145	0.0072	CcSEcCtD
Cinacalcet—Constipation—Vismodegib—skin cancer	0.00145	0.00719	CcSEcCtD
Cinacalcet—Depression—Imiquimod—skin cancer	0.0014	0.00692	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Vismodegib—skin cancer	0.00139	0.00687	CcSEcCtD
Cinacalcet—Abdominal pain—Vismodegib—skin cancer	0.00134	0.00664	CcSEcCtD
Cinacalcet—Malnutrition—Vemurafenib—skin cancer	0.00128	0.00636	CcSEcCtD
Cinacalcet—Asthenia—Vismodegib—skin cancer	0.00122	0.00603	CcSEcCtD
Cinacalcet—Pruritus—Vismodegib—skin cancer	0.0012	0.00595	CcSEcCtD
Cinacalcet—Diarrhoea—Vismodegib—skin cancer	0.00116	0.00575	CcSEcCtD
Cinacalcet—Immune system disorder—Imiquimod—skin cancer	0.00114	0.00563	CcSEcCtD
Cinacalcet—Arrhythmia—Imiquimod—skin cancer	0.00112	0.00557	CcSEcCtD
Cinacalcet—Cough—Vemurafenib—skin cancer	0.00112	0.00555	CcSEcCtD
Cinacalcet—Bone disorder—Docetaxel—skin cancer	0.0011	0.00548	CcSEcCtD
Cinacalcet—Malnutrition—Imiquimod—skin cancer	0.00109	0.00543	CcSEcCtD
Cinacalcet—Myalgia—Vemurafenib—skin cancer	0.00109	0.00542	CcSEcCtD
Cinacalcet—Arthralgia—Vemurafenib—skin cancer	0.00109	0.00542	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00108	0.00538	CcSEcCtD
Cinacalcet—Vomiting—Vismodegib—skin cancer	0.00108	0.00534	CcSEcCtD
Cinacalcet—Rash—Vismodegib—skin cancer	0.00107	0.0053	CcSEcCtD
Cinacalcet—Dermatitis—Vismodegib—skin cancer	0.00107	0.00529	CcSEcCtD
Cinacalcet—Infection—Vemurafenib—skin cancer	0.00104	0.00516	CcSEcCtD
Cinacalcet—Cardiac failure—Fluorouracil—skin cancer	0.00103	0.0051	CcSEcCtD
Cinacalcet—Nervous system disorder—Vemurafenib—skin cancer	0.00103	0.00509	CcSEcCtD
Cinacalcet—Skin disorder—Vemurafenib—skin cancer	0.00102	0.00504	CcSEcCtD
Cinacalcet—Dehydration—Temozolomide—skin cancer	0.00101	0.00502	CcSEcCtD
Cinacalcet—Floctafenine—PTGS2—skin cancer	0.00101	1	CrCbGaD
Cinacalcet—Nausea—Vismodegib—skin cancer	0.00101	0.00499	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.001	0.00497	CcSEcCtD
Cinacalcet—Angioedema—Imiquimod—skin cancer	0.001	0.00496	CcSEcCtD
Cinacalcet—Hypotension—Vemurafenib—skin cancer	0.000978	0.00485	CcSEcCtD
Cinacalcet—Cough—Imiquimod—skin cancer	0.000955	0.00473	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000954	0.00473	CcSEcCtD
Cinacalcet—Convulsion—Imiquimod—skin cancer	0.000948	0.0047	CcSEcCtD
Cinacalcet—Hypertension—Imiquimod—skin cancer	0.000945	0.00468	CcSEcCtD
Cinacalcet—Arthralgia—Imiquimod—skin cancer	0.000931	0.00462	CcSEcCtD
Cinacalcet—Chest pain—Imiquimod—skin cancer	0.000931	0.00462	CcSEcCtD
Cinacalcet—Myalgia—Imiquimod—skin cancer	0.000931	0.00462	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000925	0.00459	CcSEcCtD
Cinacalcet—Decreased appetite—Vemurafenib—skin cancer	0.00091	0.00451	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000904	0.00448	CcSEcCtD
Cinacalcet—Fatigue—Vemurafenib—skin cancer	0.000903	0.00448	CcSEcCtD
Cinacalcet—Constipation—Vemurafenib—skin cancer	0.000895	0.00444	CcSEcCtD
Cinacalcet—Infection—Imiquimod—skin cancer	0.000887	0.0044	CcSEcCtD
Cinacalcet—Nervous system disorder—Imiquimod—skin cancer	0.000876	0.00434	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Temozolomide—skin cancer	0.000875	0.00434	CcSEcCtD
Cinacalcet—Skin disorder—Imiquimod—skin cancer	0.000867	0.0043	CcSEcCtD
Cinacalcet—Anorexia—Imiquimod—skin cancer	0.000851	0.00422	CcSEcCtD
Cinacalcet—Depression—Temozolomide—skin cancer	0.000837	0.00415	CcSEcCtD
Cinacalcet—Body temperature increased—Vemurafenib—skin cancer	0.000828	0.0041	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000814	0.00403	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000806	0.004	CcSEcCtD
Cinacalcet—Paraesthesia—Imiquimod—skin cancer	0.000802	0.00398	CcSEcCtD
Cinacalcet—Dyspnoea—Imiquimod—skin cancer	0.000796	0.00395	CcSEcCtD
Cinacalcet—Dyspepsia—Imiquimod—skin cancer	0.000786	0.0039	CcSEcCtD
Cinacalcet—Decreased appetite—Imiquimod—skin cancer	0.000776	0.00385	CcSEcCtD
Cinacalcet—Hypersensitivity—Vemurafenib—skin cancer	0.000771	0.00383	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Imiquimod—skin cancer	0.000771	0.00382	CcSEcCtD
Cinacalcet—Fatigue—Imiquimod—skin cancer	0.00077	0.00382	CcSEcCtD
Cinacalcet—Asthenia—Vemurafenib—skin cancer	0.000751	0.00373	CcSEcCtD
Cinacalcet—Oedema peripheral—Temozolomide—skin cancer	0.000742	0.00368	CcSEcCtD
Cinacalcet—Cardiac failure—Docetaxel—skin cancer	0.000742	0.00368	CcSEcCtD
Cinacalcet—Pruritus—Vemurafenib—skin cancer	0.000741	0.00367	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Imiquimod—skin cancer	0.00073	0.00362	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000724	0.00359	CcSEcCtD
Cinacalcet—Pain in extremity—Docetaxel—skin cancer	0.000724	0.00359	CcSEcCtD
Cinacalcet—Anaemia—Bleomycin—skin cancer	0.000718	0.00356	CcSEcCtD
Cinacalcet—Diarrhoea—Vemurafenib—skin cancer	0.000716	0.00355	CcSEcCtD
Cinacalcet—Urticaria—Imiquimod—skin cancer	0.000709	0.00352	CcSEcCtD
Cinacalcet—Abdominal pain—Imiquimod—skin cancer	0.000706	0.0035	CcSEcCtD
Cinacalcet—Body temperature increased—Imiquimod—skin cancer	0.000706	0.0035	CcSEcCtD
Cinacalcet—Dizziness—Vemurafenib—skin cancer	0.000692	0.00343	CcSEcCtD
Cinacalcet—Immune system disorder—Temozolomide—skin cancer	0.00068	0.00337	CcSEcCtD
Cinacalcet—Cough—Bleomycin—skin cancer	0.000678	0.00336	CcSEcCtD
Cinacalcet—Dehydration—Docetaxel—skin cancer	0.000673	0.00334	CcSEcCtD
Cinacalcet—Anaemia—Dactinomycin—skin cancer	0.00067	0.00332	CcSEcCtD
Cinacalcet—Vomiting—Vemurafenib—skin cancer	0.000666	0.0033	CcSEcCtD
Cinacalcet—Chest pain—Bleomycin—skin cancer	0.000662	0.00328	CcSEcCtD
Cinacalcet—Myalgia—Bleomycin—skin cancer	0.000662	0.00328	CcSEcCtD
Cinacalcet—Rash—Vemurafenib—skin cancer	0.00066	0.00327	CcSEcCtD
Cinacalcet—Dermatitis—Vemurafenib—skin cancer	0.00066	0.00327	CcSEcCtD
Cinacalcet—Hypersensitivity—Imiquimod—skin cancer	0.000658	0.00326	CcSEcCtD
Cinacalcet—Headache—Vemurafenib—skin cancer	0.000656	0.00325	CcSEcCtD
Cinacalcet—Malnutrition—Temozolomide—skin cancer	0.000656	0.00325	CcSEcCtD
Cinacalcet—Cramp muscle—Docetaxel—skin cancer	0.000652	0.00323	CcSEcCtD
Cinacalcet—Asthenia—Imiquimod—skin cancer	0.000641	0.00318	CcSEcCtD
Cinacalcet—Pruritus—Imiquimod—skin cancer	0.000632	0.00313	CcSEcCtD
Cinacalcet—Infection—Bleomycin—skin cancer	0.00063	0.00313	CcSEcCtD
Cinacalcet—Nausea—Vemurafenib—skin cancer	0.000622	0.00308	CcSEcCtD
Cinacalcet—Arrhythmia—Fluorouracil—skin cancer	0.00062	0.00307	CcSEcCtD
Cinacalcet—CYP1A2—nipple—skin cancer	0.000619	0.0525	CbGeAlD
Cinacalcet—Myalgia—Dactinomycin—skin cancer	0.000617	0.00306	CcSEcCtD
Cinacalcet—Diarrhoea—Imiquimod—skin cancer	0.000611	0.00303	CcSEcCtD
Cinacalcet—Anaemia—Temozolomide—skin cancer	0.000606	0.00301	CcSEcCtD
Cinacalcet—Anorexia—Bleomycin—skin cancer	0.000605	0.003	CcSEcCtD
Cinacalcet—Angioedema—Temozolomide—skin cancer	0.000599	0.00297	CcSEcCtD
Cinacalcet—Hypotension—Bleomycin—skin cancer	0.000593	0.00294	CcSEcCtD
Cinacalcet—Dizziness—Imiquimod—skin cancer	0.00059	0.00293	CcSEcCtD
Cinacalcet—Infection—Dactinomycin—skin cancer	0.000588	0.00291	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000578	0.00287	CcSEcCtD
Cinacalcet—Cough—Temozolomide—skin cancer	0.000572	0.00284	CcSEcCtD
Cinacalcet—Paraesthesia—Bleomycin—skin cancer	0.00057	0.00282	CcSEcCtD
Cinacalcet—Convulsion—Temozolomide—skin cancer	0.000568	0.00282	CcSEcCtD
Cinacalcet—Vomiting—Imiquimod—skin cancer	0.000568	0.00282	CcSEcCtD
Cinacalcet—Hypertension—Temozolomide—skin cancer	0.000566	0.00281	CcSEcCtD
Cinacalcet—Dyspnoea—Bleomycin—skin cancer	0.000566	0.0028	CcSEcCtD
Cinacalcet—Anorexia—Dactinomycin—skin cancer	0.000564	0.0028	CcSEcCtD
Cinacalcet—Rash—Imiquimod—skin cancer	0.000563	0.00279	CcSEcCtD
Cinacalcet—Dermatitis—Imiquimod—skin cancer	0.000562	0.00279	CcSEcCtD
Cinacalcet—Headache—Imiquimod—skin cancer	0.000559	0.00277	CcSEcCtD
Cinacalcet—Anaemia—Fluorouracil—skin cancer	0.000558	0.00277	CcSEcCtD
Cinacalcet—Myalgia—Temozolomide—skin cancer	0.000558	0.00277	CcSEcCtD
Cinacalcet—Arthralgia—Temozolomide—skin cancer	0.000558	0.00277	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000554	0.00275	CcSEcCtD
Cinacalcet—Decreased appetite—Bleomycin—skin cancer	0.000551	0.00273	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000539	0.00267	CcSEcCtD
Cinacalcet—Infection—Temozolomide—skin cancer	0.000532	0.00264	CcSEcCtD
Cinacalcet—Nausea—Imiquimod—skin cancer	0.00053	0.00263	CcSEcCtD
Cinacalcet—Nervous system disorder—Temozolomide—skin cancer	0.000525	0.0026	CcSEcCtD
Cinacalcet—Convulsion—Fluorouracil—skin cancer	0.000523	0.0026	CcSEcCtD
Cinacalcet—Skin disorder—Temozolomide—skin cancer	0.00052	0.00258	CcSEcCtD
Cinacalcet—Chest pain—Fluorouracil—skin cancer	0.000514	0.00255	CcSEcCtD
Cinacalcet—Myalgia—Fluorouracil—skin cancer	0.000514	0.00255	CcSEcCtD
Cinacalcet—Decreased appetite—Dactinomycin—skin cancer	0.000514	0.00255	CcSEcCtD
Cinacalcet—Fatigue—Dactinomycin—skin cancer	0.00051	0.00253	CcSEcCtD
Cinacalcet—Anorexia—Temozolomide—skin cancer	0.00051	0.00253	CcSEcCtD
Cinacalcet—Urticaria—Bleomycin—skin cancer	0.000504	0.0025	CcSEcCtD
Cinacalcet—Body temperature increased—Bleomycin—skin cancer	0.000501	0.00249	CcSEcCtD
Cinacalcet—Oedema peripheral—Docetaxel—skin cancer	0.000493	0.00245	CcSEcCtD
Cinacalcet—Infection—Fluorouracil—skin cancer	0.00049	0.00243	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000488	0.00242	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Dactinomycin—skin cancer	0.000484	0.0024	CcSEcCtD
Cinacalcet—Nervous system disorder—Fluorouracil—skin cancer	0.000483	0.0024	CcSEcCtD
Cinacalcet—Paraesthesia—Temozolomide—skin cancer	0.00048	0.00238	CcSEcCtD
Cinacalcet—Dyspnoea—Temozolomide—skin cancer	0.000477	0.00237	CcSEcCtD
Cinacalcet—Dyspepsia—Temozolomide—skin cancer	0.000471	0.00234	CcSEcCtD
Cinacalcet—Anorexia—Fluorouracil—skin cancer	0.00047	0.00233	CcSEcCtD
Cinacalcet—Abdominal pain—Dactinomycin—skin cancer	0.000468	0.00232	CcSEcCtD
Cinacalcet—Body temperature increased—Dactinomycin—skin cancer	0.000468	0.00232	CcSEcCtD
Cinacalcet—Hypersensitivity—Bleomycin—skin cancer	0.000467	0.00232	CcSEcCtD
Cinacalcet—Decreased appetite—Temozolomide—skin cancer	0.000465	0.00231	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Temozolomide—skin cancer	0.000462	0.00229	CcSEcCtD
Cinacalcet—Fatigue—Temozolomide—skin cancer	0.000461	0.00229	CcSEcCtD
Cinacalcet—Hypotension—Fluorouracil—skin cancer	0.000461	0.00228	CcSEcCtD
Cinacalcet—Constipation—Temozolomide—skin cancer	0.000458	0.00227	CcSEcCtD
Cinacalcet—Asthenia—Bleomycin—skin cancer	0.000455	0.00226	CcSEcCtD
Cinacalcet—Immune system disorder—Docetaxel—skin cancer	0.000452	0.00224	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000449	0.00223	CcSEcCtD
Cinacalcet—Pruritus—Bleomycin—skin cancer	0.000449	0.00223	CcSEcCtD
Cinacalcet—Arrhythmia—Docetaxel—skin cancer	0.000447	0.00222	CcSEcCtD
Cinacalcet—Paraesthesia—Fluorouracil—skin cancer	0.000443	0.0022	CcSEcCtD
Cinacalcet—Dyspnoea—Fluorouracil—skin cancer	0.00044	0.00218	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Temozolomide—skin cancer	0.000438	0.00217	CcSEcCtD
Cinacalcet—Malnutrition—Docetaxel—skin cancer	0.000436	0.00216	CcSEcCtD
Cinacalcet—Hypersensitivity—Dactinomycin—skin cancer	0.000436	0.00216	CcSEcCtD
Cinacalcet—Dyspepsia—Fluorouracil—skin cancer	0.000434	0.00215	CcSEcCtD
Cinacalcet—Decreased appetite—Fluorouracil—skin cancer	0.000429	0.00213	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000426	0.00211	CcSEcCtD
Cinacalcet—Urticaria—Temozolomide—skin cancer	0.000425	0.00211	CcSEcCtD
Cinacalcet—Asthenia—Dactinomycin—skin cancer	0.000424	0.00211	CcSEcCtD
Cinacalcet—Body temperature increased—Temozolomide—skin cancer	0.000423	0.0021	CcSEcCtD
Cinacalcet—Abdominal pain—Temozolomide—skin cancer	0.000423	0.0021	CcSEcCtD
Cinacalcet—Muscle spasms—Docetaxel—skin cancer	0.000419	0.00208	CcSEcCtD
Cinacalcet—Diarrhoea—Dactinomycin—skin cancer	0.000405	0.00201	CcSEcCtD
Cinacalcet—Vomiting—Bleomycin—skin cancer	0.000403	0.002	CcSEcCtD
Cinacalcet—Anaemia—Docetaxel—skin cancer	0.000403	0.002	CcSEcCtD
Cinacalcet—Rash—Bleomycin—skin cancer	0.0004	0.00198	CcSEcCtD
Cinacalcet—Dermatitis—Bleomycin—skin cancer	0.0004	0.00198	CcSEcCtD
Cinacalcet—Hypersensitivity—Temozolomide—skin cancer	0.000394	0.00196	CcSEcCtD
Cinacalcet—Urticaria—Fluorouracil—skin cancer	0.000392	0.00194	CcSEcCtD
Cinacalcet—Body temperature increased—Fluorouracil—skin cancer	0.00039	0.00193	CcSEcCtD
Cinacalcet—Asthenia—Temozolomide—skin cancer	0.000384	0.0019	CcSEcCtD
Cinacalcet—Cough—Docetaxel—skin cancer	0.00038	0.00189	CcSEcCtD
Cinacalcet—Pruritus—Temozolomide—skin cancer	0.000379	0.00188	CcSEcCtD
Cinacalcet—Convulsion—Docetaxel—skin cancer	0.000378	0.00187	CcSEcCtD
Cinacalcet—Nausea—Bleomycin—skin cancer	0.000377	0.00187	CcSEcCtD
Cinacalcet—Hypertension—Docetaxel—skin cancer	0.000376	0.00187	CcSEcCtD
Cinacalcet—Vomiting—Dactinomycin—skin cancer	0.000376	0.00187	CcSEcCtD
Cinacalcet—Rash—Dactinomycin—skin cancer	0.000373	0.00185	CcSEcCtD
Cinacalcet—Arthralgia—Docetaxel—skin cancer	0.000371	0.00184	CcSEcCtD
Cinacalcet—Chest pain—Docetaxel—skin cancer	0.000371	0.00184	CcSEcCtD
Cinacalcet—Myalgia—Docetaxel—skin cancer	0.000371	0.00184	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000369	0.00183	CcSEcCtD
Cinacalcet—Diarrhoea—Temozolomide—skin cancer	0.000366	0.00182	CcSEcCtD
Cinacalcet—Hypersensitivity—Fluorouracil—skin cancer	0.000363	0.0018	CcSEcCtD
Cinacalcet—Dizziness—Temozolomide—skin cancer	0.000354	0.00175	CcSEcCtD
Cinacalcet—Infection—Docetaxel—skin cancer	0.000354	0.00175	CcSEcCtD
Cinacalcet—Nausea—Dactinomycin—skin cancer	0.000351	0.00174	CcSEcCtD
Cinacalcet—Nervous system disorder—Docetaxel—skin cancer	0.000349	0.00173	CcSEcCtD
Cinacalcet—Pruritus—Fluorouracil—skin cancer	0.000349	0.00173	CcSEcCtD
Cinacalcet—Skin disorder—Docetaxel—skin cancer	0.000346	0.00171	CcSEcCtD
Cinacalcet—Vomiting—Temozolomide—skin cancer	0.00034	0.00169	CcSEcCtD
Cinacalcet—Anorexia—Docetaxel—skin cancer	0.000339	0.00168	CcSEcCtD
Cinacalcet—Rash—Temozolomide—skin cancer	0.000337	0.00167	CcSEcCtD
Cinacalcet—Diarrhoea—Fluorouracil—skin cancer	0.000337	0.00167	CcSEcCtD
Cinacalcet—Dermatitis—Temozolomide—skin cancer	0.000337	0.00167	CcSEcCtD
Cinacalcet—Headache—Temozolomide—skin cancer	0.000335	0.00166	CcSEcCtD
Cinacalcet—Hypotension—Docetaxel—skin cancer	0.000333	0.00165	CcSEcCtD
Cinacalcet—Dizziness—Fluorouracil—skin cancer	0.000326	0.00162	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000324	0.00161	CcSEcCtD
Cinacalcet—Paraesthesia—Docetaxel—skin cancer	0.00032	0.00158	CcSEcCtD
Cinacalcet—Nausea—Temozolomide—skin cancer	0.000318	0.00158	CcSEcCtD
Cinacalcet—Dyspnoea—Docetaxel—skin cancer	0.000317	0.00157	CcSEcCtD
Cinacalcet—Vomiting—Fluorouracil—skin cancer	0.000313	0.00155	CcSEcCtD
Cinacalcet—Dyspepsia—Docetaxel—skin cancer	0.000313	0.00155	CcSEcCtD
Cinacalcet—Rash—Fluorouracil—skin cancer	0.000311	0.00154	CcSEcCtD
Cinacalcet—Dermatitis—Fluorouracil—skin cancer	0.000311	0.00154	CcSEcCtD
Cinacalcet—Decreased appetite—Docetaxel—skin cancer	0.000309	0.00153	CcSEcCtD
Cinacalcet—Headache—Fluorouracil—skin cancer	0.000309	0.00153	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Docetaxel—skin cancer	0.000307	0.00152	CcSEcCtD
Cinacalcet—Fatigue—Docetaxel—skin cancer	0.000307	0.00152	CcSEcCtD
Cinacalcet—Constipation—Docetaxel—skin cancer	0.000304	0.00151	CcSEcCtD
Cinacalcet—Nausea—Fluorouracil—skin cancer	0.000293	0.00145	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Docetaxel—skin cancer	0.000291	0.00144	CcSEcCtD
Cinacalcet—Body temperature increased—Docetaxel—skin cancer	0.000281	0.0014	CcSEcCtD
Cinacalcet—Abdominal pain—Docetaxel—skin cancer	0.000281	0.0014	CcSEcCtD
Cinacalcet—Hypersensitivity—Docetaxel—skin cancer	0.000262	0.0013	CcSEcCtD
Cinacalcet—Asthenia—Docetaxel—skin cancer	0.000255	0.00127	CcSEcCtD
Cinacalcet—Pruritus—Docetaxel—skin cancer	0.000252	0.00125	CcSEcCtD
Cinacalcet—Diarrhoea—Docetaxel—skin cancer	0.000243	0.00121	CcSEcCtD
Cinacalcet—Dizziness—Docetaxel—skin cancer	0.000235	0.00117	CcSEcCtD
Cinacalcet—Vomiting—Docetaxel—skin cancer	0.000226	0.00112	CcSEcCtD
Cinacalcet—Rash—Docetaxel—skin cancer	0.000224	0.00111	CcSEcCtD
Cinacalcet—Dermatitis—Docetaxel—skin cancer	0.000224	0.00111	CcSEcCtD
Cinacalcet—CYP3A4—female reproductive system—skin cancer	0.000224	0.019	CbGeAlD
Cinacalcet—Headache—Docetaxel—skin cancer	0.000223	0.00111	CcSEcCtD
Cinacalcet—CYP2D6—female reproductive system—skin cancer	0.00022	0.0187	CbGeAlD
Cinacalcet—Nausea—Docetaxel—skin cancer	0.000211	0.00105	CcSEcCtD
Cinacalcet—CYP2D6—head—skin cancer	0.000184	0.0156	CbGeAlD
